BML Capital Management 13F-HRQuarterly holdings report by institutional manager

Filed: 23 Apr 24, 4:47pm

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL

OMB Number:		3235-0006
Expires:	Oct 31, 2018
Estimated average burden
hours per response:		23.8

COLUMN 1	COLUMN 2	COLUMN 3	COLUMN 4	COLUMN 5			COLUMN 6	COLUMN 7	COLUMN 8
			VALUE	SHRS OR	SH/	PUT/	INVESTMENT	OTHER	VOTING AUTHORITY
NAME OF ISSUER	TITLE OF CLASS	CUSIP	(x$1000)	PRN AMT	PRN	CALL	DISCRETION	MANAGER	SOLE	SHARED	NONE
ARCA BIOPHARMA INC	COM	00211Y506	1,244,197	706,930	SH		SOLE		0	0	706,930
ACLARIS THERAPEUTICS INC	COM	00461U105	11,650,958	9,395,934	SH		SOLE		0	0	9,395,934
ADVERUM BIOTECHNOLOGIES INC	COM NEW	00773U207	11,780,274	833,117	SH		SOLE		0	0	833,117
ALLOVIR INC	COM	019818103	151,330	200,464	SH		SOLE		0	0	200,464
ASTROTECH CORP	COM	046484309	1,972,647	220,410	SH		SOLE		0	0	220,410
ATEA PHARMACEUTICALS INC	COM	04683R106	22,368,308	5,536,710	SH		SOLE		0	0	5,536,710
ATHIRA PHARMA INC	COM	04746L104	2,466,000	900,000	SH		SOLE		0	0	900,000
AVROBIO INC	COM	05455M100	5,122,083	4,001,627	SH		SOLE		0	0	4,001,627
LISATA THERAPEUTICS INC	COM	128058302	888,167	284,669	SH		SOLE		0	0	284,669
CONNECT BIOPHARMA HLDGS LTD	ADS	207523101	3,586,728	2,061,338	SH		SOLE		0	0	2,061,338
CYTEIR THERAPEUTICS INC	COM	23284P103	10,998,700	3,654,053	SH		SOLE		0	0	3,654,053
DESIGN THERAPEUTICS INC	COM	25056L103	3,544,296	879,478	SH		SOLE		0	0	879,478
ELIEM THERAPEUTICS INC	COM	28658R106	6,010,853	2,193,742	SH		SOLE		0	0	2,193,742
ENLIVEN THERAPEUTICS INC	COM	29337E102	881,259	50,100	SH		SOLE		0	0	50,100
FORTE BIOSCIENCES INC	COM	34962G109	1,226,497	1,761,702	SH		SOLE		0	0	1,761,702
CALCIMEDICA INC	COM NEW	38942Q202	667,364	160,424	SH		SOLE		0	0	160,424
INSTIL BIO INC	COM NEW	45783C200	3,766,338	348,735	SH		SOLE		0	0	348,735
ISHARES TR	0-3 MNTH TREASRY	46436E718	27,191,700	270,000	SH		SOLE		0	0	270,000
KINNATE BIOPHARMA INC	COM	49705R105	1,326,944	498,851	SH		SOLE		0	0	498,851
LENZ THERAPEUTICS INC	COM	52635N103	1,427,244	63,916	SH		SOLE		0	0	63,916
MILESTONE PHARMACEUTICALS IN	COM	59935V107	1,085,000	606,145	SH		SOLE		0	0	606,145
NEXTCURE INC	COM	65343E108	683,417	306,465	SH		SOLE		0	0	306,465
ORAMED PHARMACEUTICALS INC	COM NEW	68403P203	2,465,928	844,496	SH		SOLE		0	0	844,496
PMV PHARMACEUTICALS INC	COM	69353Y103	2,221,033	1,306,490	SH		SOLE		0	0	1,306,490
Q32 BIO INC	COM	746964105	424,194	24,894	SH		SOLE		0	0	24,894
RENEO PHARMACEUTICALS INC	COM	75974E103	3,615,336	2,177,913	SH		SOLE		0	0	2,177,913
SPDR SER TR	BLOOMBERG 1-3 MO	78468R663	18,360,000	200,000	SH		SOLE		0	0	200,000
TALIS BIOMEDICAL CORP	COM NEW	87424L207	374,001	42,743	SH		SOLE		0	0	42,743
VERRICA PHARMACEUTICALS INC	COM	92511W108	1,065,600	180,000	SH		SOLE		0	0	180,000
VISTAGEN THERAPEUTICS INC	COM	92840H400	792,000	150,000	SH		SOLE		0	0	150,000

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.